“…Numerous authors have localized the peptide by immunological methods in different regions of the brain [I, 6-8, 12, 13, 17, 19, 22, 28, 30]. Immunopositive nerve terminals are present in the hypothalamus, and cell bodies in the arcuate nucleus are immunoreactive for a-MSH [18]. In addition, due to the presence of a-MSH in hypothalamic synaptosomes [8] and of Ca-dependent a-MSH release [I, 16, 23], a neuromodulator or neurotrans mitter role for a-MSH in the hypothalamus and perhaps in the central nervous system was postulated.…”